TABLE 3.
Factors affecting LOS of index SLKT admission
| Variables | Betaa (95% CI) | P | LOS change per unit (%) |
|---|---|---|---|
| Intercept | 1.78 (1.15-2.41) | <0.001 | |
| Age (per y) | 0.009 (0.003-0.014) | 0.002 | 0.9% |
| Race (vs White) Black Others | 0.21 (0.039-0.38)0.062 (–0.12 to 0.24) | 0.02 0.50 | 23.5% 6.4% |
| Female (vs male) | 0.20 (0.092-0.31) | <0.001 | 22.5% |
| Etiology (vs others) Alcohol Hepatitis C NASH | –0.02 (–0.17 to 0.14)0.05 (–0.10 to 0.20)0.10 (–0.07 to 0.27) | 0.830.530.25 | –1.7%4.9%10.7% |
| Status at SLKT (vs ambulatory) Admitted to floor Admitted to ICU | 0.13 (–0.067 to 0.32)0.22 (0.016-0.42) | 0.19 0.03 | 13.6% 24.5% |
| Dialysis pre-SLKT (ref = No) | 0.21 (0.087-0.33) | <0.001 | 23.3% |
| BMI (vs <18.5 kg/m2-underweight) 18.5–25 kg/m2 26–29 kg/m2 ≥30 kg/m2 | –0.11 (–0.54-0.33)–0.18 (–0.61-0.26)–0.19 (–0.62-0.25) | 0.630.420.40 | –10.1%–16.1%–17.2% |
| Era (<2008–Era 1)2008–2012 (Era 2)>2012 (Era 3) | 0.05 (–0.09-0.19)(0.04 (–0.10-0.19) | 0.480.55 | 5.4%4.5% |
| Pre-LT hypertension (vs no) | –0.11 (–0.23-0.01) | 0.06 | –10.5% |
| Pre-LT DM (vs no) | 0.11 (–0.02-0.24) | 0.10 | 11.4% |
| Cyclosporine (vs tacrolimus) | 0.28 (0.027-0.54) | 0.03 | 32.6% |
| MELD-Na at SLKT | 0.011 (0.004-0.018) | 0.003 | 1.1% |
| KDGF (ref = No) | 0.36 (0.22-0.51) | <0.001 | 30.5% |
| RRI | –0.018 (–0.028 to –0.008) | <0.001 | –1.8% |
| Donor age (per y) | 0.002 (–0.002-0.006) | 0.29 | 0.2% |
| CIT (per min) | 0.0002(–0.0002-0.0005) | 0.32 | 0.02% |
| WIT (per min) | –0.001 (–0.002-0.001) | 0.48 | –0.06% |
aThis model was also adjusted for the centers.
BMI, body mass index; CI, confidence intervals; CIT, cold ischemia time; DM, diabetes; ICU, intensive care unit; LOS, length of stay; LT, liver transplant; SLKT, simultaneous liver-kidney transplant; WIT, warm ischemia time.